Advertisement

Latest Articles in pharmaceuticals

Vaccination For Delhi Belly May Soon Enter Market

The adult vaccine market in India is very small compared to the paediatric market, however, exact sales figures are not available

Read More

Implementation May Remain Biggest Challenge For National Health Policy

The draft proposals are well articulated but the challenge lies in the implementation of the policy, says Sujay Shetty, leader of pharmaceuticals and life sciences at consultancy PwC India

Read More

National Health Policy Suggests 1.5% Rise In Spending, Maximum Focus On Primary Care

The biggest failure in India's public healthcare system has been the poor focus on providing primary healthcare

Read More

Foreign Firms Reluctant To Launch New Drugs In India, Says GIPC

The executive director of international intellectual property at GIPC is in India to talk about the simmering discontent over IPR infrastructure

Read More

Affordability At Cost Of Innovation?

Stents and other cost issues in the context of affordability of healthcare in India assume importance as price control can also affect innovation

Read More

Pharma Sector Growth To Be Moderate: ICRA

According to rating agency ICRA, revenue from US during from 2011-15 period, rose at an average 33 per cent

Read More

Medical Tourism To Keep Pharma Industry In Good Health: Study

The pharmaceuticals market expanded at a CAGR of 17.46 per cent during 2005-16, from $6 billion in 2005 to $36.7 billion in 2016

Read More

ISCR Launches Causality Assessment Portal At Its 10th Annual Conference

The theme of the two-day conference was 'Clinical Research in India – Patients First & Research for Patients'

Read More

Dr Reddy's December Quarter Net Profit Falls 16 Per Cent

Sales in North America, Dr Reddy's largest market, fell 15 percent, while those in India were up 2.4 percent, the company said in a statement

Read More

Pfizer Posts Rs 60.5 Crore Net Profit In December Quarter

Revenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year

Read More

Johnson & Johnson To Buy Actelion For $30 Billion

Offer worth $280 a share plus one share in new R&D company; New R&D company to develop Actelion experimental drugs

Read More

Biopharma: India's New Sunrise Sector

India requires a dual focus on entrepreneurship and innovation, as well as removing the barriers to new investment and improving the overall climate for business

Read More

Setting The Tone And Tenor In Medical Excellence

CEMAST is the world's first center offering courses in 11 specialities for minimal access surgery. In laparoscopic segment alone, the centre trained over 1,000 rural doctors

Read More